iTeos Therapeutics (NASDAQ:ITOS) Price Target Lowered to $19.00 at Wells Fargo & Company

iTeos Therapeutics (NASDAQ:ITOS – Get Free Report) had its target price decreased by analysts at Wells Fargo & Company from $31.00 to $19.00 in a report issued on Thursday,Benzinga reports. The firm presently has an “overweight” rating on the stock. Wells Fargo & Company‘s target price indicates a potential upside of 161.71% from the stock’s […]

Leave a Reply

Your email address will not be published.

Previous post Morgan Stanley Issues Positive Forecast for Block (NYSE:SQ) Stock Price
Next post 2025 Audi Q6 and SQ6 e-tron: Electric SUV Performance